Table 4.
Model | Sensitivity, % | Specificity, % | |
---|---|---|---|
Biomarker Panel | Training | 90.0 | 61.1 |
95.0 | 47.8 | ||
99.0 | 27.2 | ||
62.8 | 90.0 | ||
57.8 | 95.0 | ||
54.8 | 99.0 | ||
Validation | 90.0 | 69.3 | |
95.0 | 43.9 | ||
99.0 | 27.8 | ||
69.6 | 90.0 | ||
60.7 | 95.0 | ||
47.4 | 99.0 | ||
Nodule risk panel | Training | 90.0 | 92.2 |
95.0 | 75.8 | ||
99.0 | 44.1 | ||
91.7 | 90.0 | ||
86.4 | 95.0 | ||
73.9 | 99.0 | ||
Validation | 90.0 | 84.8 | |
95.0 | 72.7 | ||
99.0 | 39.2 | ||
85.1 | 90.0 | ||
82.2 | 95.0 | ||
70.4 | 99.0 |